Search research articles
Contact Us
Filters
Showing results (91-100 of 145) with videos related to
Page
of 15
Sort By:
Cancer Treatment and Research
|
January 1, 1990
In-vivo antibody imaging for the detection of human tumors
D M Goldenberg, H Goldenberg, R M Sharkey, et al.
Cancer Research
|
August 1, 1996
Antibody penetration of tumor GS-7 xenografts in nude mice: a model for mucinous adenocarcinoma of the colon
R D Blumenthal, R Stein, R M Sharkey, et al.
Bioconjugate Chemistry
|
July 1, 1997
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development
H Karacay, R M Sharkey, S V Govindan, et al.
Nuclear Medicine Communications
|
February 9, 1999
In vivo stability and metabolism of 99Tcm-labelled anti-CD4 monoclonal antibodies and Fab' fragments
R W Kinne, K Schemer, T Behr, et al.
Cancer Research
|
February 1, 1990
Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody
J A Siegel, D A Pawlyk, R E Lee, et al.
New Jersey Medicine : the Journal of the Medical Society of New Jersey
|
November 1, 1990
Monoclonal antibody therapy of cancer
D M Goldenberg, R M Sharkey, H Goldenberg, et al.
Cancer Research
|
January 1, 1986
Quantitative whole-body autoradiography of radiolabeled antibody distribution in a xenografted human cancer model
I Fand, R M Sharkey, W P McNally, et al.
Bioconjugate Chemistry
|
September 19, 2002
Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen
H Karacay, R M Sharkey, W J McBride, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 1999
The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments
S O Leung, Z Qu, H J Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 1999
Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma
M E Juweid, E Stadtmauer, G Hajjar, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 145) with videos related to
Sort By:
Page
of 15
Cancer Treatment and Research
|
January 1, 1990
In-vivo antibody imaging for the detection of human tumors
D M Goldenberg, H Goldenberg, R M Sharkey, et al.
Cancer Research
|
August 1, 1996
Antibody penetration of tumor GS-7 xenografts in nude mice: a model for mucinous adenocarcinoma of the colon
R D Blumenthal, R Stein, R M Sharkey, et al.
Bioconjugate Chemistry
|
July 1, 1997
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development
H Karacay, R M Sharkey, S V Govindan, et al.
Nuclear Medicine Communications
|
February 9, 1999
In vivo stability and metabolism of 99Tcm-labelled anti-CD4 monoclonal antibodies and Fab' fragments
R W Kinne, K Schemer, T Behr, et al.
Cancer Research
|
February 1, 1990
Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody
J A Siegel, D A Pawlyk, R E Lee, et al.
New Jersey Medicine : the Journal of the Medical Society of New Jersey
|
November 1, 1990
Monoclonal antibody therapy of cancer
D M Goldenberg, R M Sharkey, H Goldenberg, et al.
Cancer Research
|
January 1, 1986
Quantitative whole-body autoradiography of radiolabeled antibody distribution in a xenografted human cancer model
I Fand, R M Sharkey, W P McNally, et al.
Bioconjugate Chemistry
|
September 19, 2002
Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen
H Karacay, R M Sharkey, W J McBride, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 1999
The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments
S O Leung, Z Qu, H J Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 1999
Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma
M E Juweid, E Stadtmauer, G Hajjar, et al.
Page
of 15